ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Program

Beclomethasone

Also written as “Beclomethasone dipropionate”, “Beclometasone/Formoterol/Glycopyrrolate” and “beclomethasone”.

Its studies are mostly in Asthma · Pulmonary Disease, Chronic Obstructive · Rhinitis, Allergic, Seasonal · Rhinitis, Allergic, Perennial · Graft vs Host Disease, led by 7 companies.

Drug pageBeclomethasone: every studyMany companies study it; this page follows only the 44 they lead. All 85 studies, academic ones too, with its approvals and label.
Furthest: phase 4, since Oct 28, 202044 company-led studies, 1 open or runningNext primary completion: Jun 2028 (phase 3)

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Chiesi Farmaceuticiits history only220 open or runningphase 4since Oct 28, 2020Sep 29, 2006none ahead
Teva Pharmaceutical Industries140 open or runningphase 4since Oct 28, 2003Oct 28, 2003none ahead
Soligenixits history only30 open or runningphase 3since Jun 19, 2009Jun 19, 2009none ahead
Adamis Pharmaceuticalsits history only20 open or runningphase 3since Feb 6, 2019Feb 6, 2019none ahead
Enteron Pharmaceuticalsits history only10 open or runningphase 3since Oct 4, 2005Oct 4, 2005none ahead
Lunan Pharmaceutical Groupits history only11 open or runningphase 3since Jul 21, 2026Jul 21, 2026Jun 2028phase 3 · NCT07768891
SOFARits history only10 open or runningphase 1since Apr 26, 2021Apr 26, 2021none ahead

How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.

History and studies of Teva Pharmaceutical Industries only; the figures above count every company.

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

  1. Oct 28, 2003First study: phase 4 study in AsthmaFirst studyNCT00071552 · 49 enrolled · United States
  2. Oct 8, 2004Phase 3 study in AsthmaNCT00094016 · 440 enrolled · United States, Puerto Rico
  3. May 2, 2005Phase 3 study in AsthmaNCT00109668 · 415 enrolled · United States, Puerto Rico
  4. Nov 4, 2005Phase 4 study in AsthmaNCT00250341 · 34 enrolled · United States
  5. Mar 2, 2009Phase 2 study in Rhinitis, Allergic, SeasonalNCT00854360 · 487 enrolled · United States
  6. Sep 30, 2009Phase 3 study in Rhinitis, Allergic, PerennialNCT00988247 · 529 enrolled · United States
  7. Dec 2, 2009Phase 3 study in Rhinitis, Allergic, SeasonalNCT01024608 · 340 enrolled · United States
  8. May 27, 20102 phase 3 studies in Rhinitis, Allergic, PerennialNCT01134705, NCT01133626
  9. Feb 28, 2011Phase 3 study in Rhinitis, Allergic, SeasonalNCT01307319 · 715 enrolled · United States
  10. Jan 31, 2013Phase 3 study in Rhinitis, AllergicNCT01783548 · 547 enrolled · United States
  11. Jan 7, 20143 phase 3 studies in AsthmaNCT02031640, NCT02040779, NCT02040766

TargetBeta

NR3C1 →read by rule
“Glucocorticoid receptor agonist”ChEMBL 37, by rule

Other programs on NR3C1

ProgramCompanyFurthest phaseStudies
DexamethasoneruleAbbViephase 4174
BudesonideruleAstraZenecaphase 4167
fluticasone furoateruleGlaxoSmithKlinephase 497
PrednisoneruleJohnson & Johnsonphase 465
PrednisoloneruleSanofiphase 434
betamethasone dipropionateruleLEO Pharmaphase 427
MethylprednisolonerulePfizerphase 423
dexamethasone phosphateruleeyegate-pharmaceuticals-incphase 421
BetamethasoneruleLEO Pharmaphase 49
Triamcinoloneruleresearch-insight-llcphase 45
relacorilantruleCorcept Therapeuticsphase 322
Triamcinolone Acetonideruleclearside-biomedical-incphase 320

Studies

All 14 Teva Pharmaceutical Industries leads, newest first. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT02040779Asthma · United States3CompletedDec 24, 2014273
NCT02040766Asthma · United States, Croatia, Mexico and more3CompletedFeb 2016628
NCT02031640Asthma · United States, Germany, Hungary and more3CompletedNov 20141,113
NCT01783548Rhinitis, Allergic · United States3CompletedOct 2013547
NCT01307319Rhinitis, Allergic, Seasonal · United States3CompletedJul 2011715
NCT01134705Rhinitis, Allergic, Perennial · United States3CompletedOct 2010474
NCT01133626Rhinitis, Allergic, Perennial · United States3CompletedSep 2010107
NCT01024608Rhinitis, Allergic, Seasonal · United States3CompletedFeb 28, 2010340
NCT00988247Rhinitis, Allergic, Perennial · United States3CompletedFeb 28, 2011529
NCT00854360Rhinitis, Allergic, Seasonal · United States2CompletedMay 2009487
NCT00250341Asthma · United States4CompletedSep 30, 200734
NCT00109668Asthma · United States, Puerto Rico3CompletedSep 30, 2006415
NCT00094016Asthma · United States, Puerto Rico3CompletedJun 30, 2006440
NCT00071552Asthma · United States4TerminatedJul 31, 200649

How it is read

Names in the registry

  • “Beclomethasone dipropionate”, 6 entries
  • “Beclometasone/Formoterol/Glycopyrrolate”, 2 entries
  • “beclomethasone”, 2 entries
  • “beclomethasone dipropionate plus formoterol fumarate combination”, 2 entries
  • “Beclometasone dipropionate/Formoterol Fumarate/Glycopyrronium”, 2 entries

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.